PLAT and stroke disorder: Although the use of neuroprotective agents has generally failed as a potential therapeutic strategy following cerebral ischemia in translational trials, thrombolysis using tissue plasminogen activator (tPA) continues to be the gold standard intervention during the acute phase after stroke (van der Worp and van Gijn, 2007).